Astrazeneca Pharma India Q3 FY24 Results Live : profit falls by 46.08% YOY
Astrazeneca Pharma India declared their Q3 FY24 results on 08 Feb, 2024. The topline increased by 22.41% & the profit decreased by 46.08% YoY.
As compared to the previous quarter, the revenue declined by 1.7% and the profit decreased by 69.83%. The Selling, general & administrative expenses rose by 11.62% q-o-q & increased by 9.08% Y-o-Y.
The operating income was down by 82.67% q-o-q & decreased by 65.02% Y-o-Y. The EPS is ₹6.32 for Q3 FY24 which decreased by 46.08% Y-o-Y.
Astrazeneca Pharma India has delivered 1.11% return in the last 1 week, 68.8% return in the last 6 months, and 18.88% YTD return. Currently, Astrazeneca Pharma India has a market cap of ₹16424.88 Cr and a 52wk high/low of ₹7220.95 & ₹3098 respectively.FAQsQuestion : What is the Q3 FY24 profit/Loss as per company?Ans : ₹15.8CrQuestion : What is Q3 FY24 revenue?Ans : ₹305.79Cr Stay updated on quarterly results with our results calendarMilestone Alert!
Livemint tops charts as the fastest growing news website in the world
